Tissue engineering full-thickness skin model and construction method
By using components such as collagen and fibronectin in tissue engineering skin models, the formation of the basement membrane is promoted, the problem of separation between the dermis and the epidermis is solved, and the tight connection and enhanced barrier function is achieved, which is suitable for safety detection.
Patent Information
- Application Number
- CN202411259437.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-10
- Publication Date
- 2024-12-03
AI Technical Summary
The existing tissue-engineering skin models lack a complete basement membrane between the true epidermis, which leads to the easy separation of the epidermis from the dermis, and the basement membrane structure is discontinuous and cannot adapt to the operational needs.
By mixing bovine type I collagen, newborn bovine serum and chondroitin sulfate with dermal fibroblasts to form collagen gels and adding matrix gel and fibronectin to its surface when constructing tissue engineering full-layer skin models, promoting Rapid formation of the basement membrane and enhance the connection between the dermis and the epidermis.
The tight connection between the dermis and the epidermis is achieved, forming an ultra-molded basement membrane, enhancing the stability and barrier function of the model, and is suitable for safety detection of drugs, cosmetics and medical devices.
Smart Images

Figure CN119060941A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of skin models and relates to a tissue engineering full-thickness skin model and a construction method. Background Art
[0002] The skin includes the epidermis and dermis, as well as the basement membrane between the dermis and the epidermis. The basement membrane is mainly composed of various components such as type IV and type VII collagen, laminin, entactin / endothelin, perlecan, etc. It has the function of tightly connecting the epidermis and dermis, and can provide a strong binding force for the epidermis and dermis to avoid the separation of the epidermis under physiological conditions. In addition, the basement membrane also has the functions of determining the polarity, permeability and barrier of epidermal cells, and can provide a barrier for epidermal migration, playing an irreplaceable role in maintaining the integrity of the skin.
[0003] Tissue-engineered skin is a relatively complete tissue-engineered tissue, which is an artificial skin made by mixing dermal fibroblasts with extracellular matrix substitutes. Tissue-engineered skin with a double-layer structure of epidermis and dermis has become increasingly close to the skin structure of the human body, and can be used for safety and efficacy evaluation of cosmetics, medical devices, drugs, etc. However, to date, all tissue-engineered skins still have some defects to varying degrees, such as the lack of skin appendages, poor friction resistance of the epidermis, and easy separation of the epidermis from the dermis. The fundamental reason why the epidermis is easily separated from the dermis is that a complete basement membrane is not constructed between the true epidermis. In addition, even if a basement membrane is formed between the true epidermis, the structure of the basement membrane is discontinuous, and there will be a situation where the true epidermis's binding ability cannot adapt to the needs of the operation, resulting in true epidermis separation. Summary of the invention
[0004] The purpose of the present invention is to provide a tissue engineering full-thickness skin model and a construction method thereof, so as to solve the problem that the existing tissue engineering skin is easily separated from the true epidermis.
[0005] The present application provides a tissue engineering full-thickness skin model and construction method, which is based on dermal fibroblasts and epidermal cells during construction, and the extracellular matrix and the components required for maintaining cell growth are added to promote the formation of the dermis and epidermis. At the same time, the added matrix glue contains the components of the basement membrane, which is conducive to the anchoring, proliferation and differentiation of keratinocytes, and the components of the basement membrane contained therein provide a template for the rapid development of the basement membrane of the full-thickness skin model, promote the deposition of basement membrane components by human epidermal cells and fibroblasts, accelerate the interaction between basement membrane components, thereby facilitating the rapid formation of a basement membrane with a complete ultrastructure, and promoting the close connection of the model true epidermis. Fibronectin can promote the adhesion growth of cells to maintain the body structure and cell growth, thereby making the connection between the dermis and the epidermis tighter.
[0006] Specifically, to achieve the above purpose, the present invention adopts the following technical solutions: The present application provides a method for constructing a tissue engineering full-thickness skin model, the method comprising: S01: Mix bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate, adjust the pH value to 7.2-7.4, add dermal fibroblast suspension, mix well, and culture in a carbon dioxide incubator for 0.5-2 hours to obtain collagen gel.
[0007] After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.2-7.4. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 5 -3×10 6 The above mixture was added to the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 0.5-2 hours to obtain collagen gel.
[0008] S02: After compressing the collagen gel to a thickness of 0.3-1 mm, culture medium I is added and cultured for 3-7 days to obtain a dermis layer.
[0009] Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 0.3-1mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the transwell insert chamber reaches 1-3ml, and the liquid volume outside the chamber is equal to the liquid volume inside the chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 50-100μg / ml vitamin C solution. Place the transwell insert chamber containing collagen gel in a carbon dioxide incubator for 3-7 days, change the liquid every two days, and obtain the dermis.
[0010] S03: coating the dermis layer with matrix gel and fibronectin, and culturing in a carbon dioxide incubator for 0.5-1 h to obtain a coated dermis layer.
[0011] After the dermis culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the transwell insert. 200 μl of a mixture of matrix gel and fibronectin is added to each well of the transwell insert and cultured in a carbon dioxide incubator for 0.5-1 h to allow the matrix gel and fibronectin to coat the surface of the dermis to obtain a coated dermis. The volume ratio of matrix gel to fibronectin is (5-10):1.
[0012] Matrigel is a basement membrane matrix extracted from EHS mouse tumors rich in extracellular matrix proteins. Its main components include laminin, type IV collagen, nestin, heparin sulfate glycoprotein, growth factors and matrix metalloproteinases. Under room temperature, Matrigel polymerizes to form a three-dimensional matrix with biological activity, which can simulate the structure, composition, physical properties and function of the basement membrane of cells in vivo, and is conducive to the culture and differentiation of cells in vitro. Therefore, the basement membrane components contained in Matrigel can provide a template for the rapid development of the basement membrane of the full-thickness skin model, promote the deposition of basement membrane components by human keratinocytes and fibroblasts, thereby accelerating the interaction between basement membrane components, which is conducive to the rapid formation of a basement membrane with complete ultrastructure.
[0013] Fibronectin (FN) is a high molecular weight glycoprotein in the extracellular matrix that can promote cell adhesion and growth, and cell adhesion is a necessary condition for maintaining the body structure and completing cell growth. Therefore, coating the dermis with fibronectin can promote the adhesion and proliferation of epidermal cells, making the connection between the dermis and epidermis tighter.
[0014] In the present application, the matrix gel is diluted with DMEM, and the dilution volume ratio of the matrix gel to DMEM is 1:(1-10). The final concentration of fibronectin is 5-100 μg / ml.
[0015] S04: adding epidermal cell suspension to the coated dermis layer, standing at room temperature, adding culture medium II after adherence culture, and culturing in a carbon dioxide incubator for 2-7 days.
[0016] After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and left to stand at room temperature for 0.5-2 hours to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 1×10 5 -3×10 6 Cells / cm 2 .
[0017] After the standing is completed, culture solution II is added inside and outside the chamber to ensure that the liquid level inside and outside the chamber is balanced. Then it is placed in a carbon dioxide incubator for 2-7 days. In this application, culture solution II includes 70% DMEM, 30% F12, 0.1-10% FBS, hydrocortisone 0.2-0.8μg / ml, insulin 1-50μg / ml, adenine 10-50μg / ml, selenium 0.05-2nM, progesterone 0.1-3nM, transferrin 10-20ng / ml and epidermal growth factor 0.2-10ng / ml.
[0018] S05: After the culture is completed, the culture medium II is replaced with culture medium III and then cultured at the air-liquid interface for 7-14 days to obtain a full-thickness skin model.
[0019] After the epidermal cell culture is completed, the culture medium II is replaced with the culture medium III and then the air-liquid interface culture is carried out for 7-14 days, and the culture medium is replaced every day to obtain a full-thickness skin model. Among them, the culture medium III includes 50% DMEM, 50% F12, 1-10% FBS, hydrocortisone 0.2-0.8μg / ml, insulin 1-50μg / ml, adenine 10-50μg / ml, selenium 0.05-2nM, progesterone 0.1-3nM, transferrin 10-20ng / ml, epidermal growth factor 0.2-10ng / ml, vitamin C 50-100μg / ml.
[0020] In addition, the present application also provides a tissue engineering full-thickness skin model, which is prepared according to the above-mentioned construction method.
[0021] The present invention has the following beneficial effects: (1) The basement membrane components contained in the matrix gel are beneficial to the anchoring, proliferation, and differentiation of keratinocytes, and thus to the formation of the basement membrane in vitro. At the same time, the basement membrane components contained in the matrix gel provide a template for the rapid development of the basement membrane of the full-thickness skin model, promote the deposition of basement membrane components by human epidermal cells and fibroblasts, and accelerate the interaction between basement membrane components, thereby facilitating the rapid formation of a basement membrane with complete ultrastructure and promoting tight connection between the model's true epidermis.
[0022] (2) Fibronectin can promote cell adhesion and growth, and cell adhesion is a necessary condition for maintaining the body structure and completing cell growth. Therefore, coating the surface of the dermis with fibronectin can promote the adhesion and proliferation of epidermal cells, making the connection between the dermis and epidermis tighter.
[0023] (3) Adding matrix gel and fibronectin to the surface of the dermis can affect the interaction between dermal fibroblasts and epidermal cells and promote the formation of basement membrane.
[0024] (4) Adding extracellular matrix components and components required to maintain cell growth to dermal fibroblasts is beneficial to promoting the growth and proliferation of dermal fibroblasts, promoting the secretion of extracellular matrix components by dermal cells, and accelerating the formation of the dermis.
[0025] (5) The full-thickness skin model consists of the epidermis, basement membrane and dermis, and the layers are tightly connected, similar to the structure of normal skin. It can be used for safety or efficacy testing of drugs, chemicals, cosmetics, disposable medical devices and other products. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 HE staining (English name: hematoxylin-eosin staining; Chinese name: hematoxylin-eosin staining) of the full-thickness skin model in Example 1 of the present application; Figure 2 HE staining of the full-thickness skin model in the control group; Figure 3 This is a type IV collagen staining image of the full-thickness skin model in Example 1 of the present application; Figure 4 This is a type VII collagen staining image of the full-thickness skin model in Example 1 of the present application; Figure 5 This is the type IV collagen staining image of the full-thickness skin model in the control group; Figure 6 This is the type VII collagen staining image of the full-thickness skin model in the control group. DETAILED DESCRIPTION
[0027] The technical solution of the present invention is further explained and illustrated by means of specific embodiments below.
[0028] Example 1 The present application embodiment provides a tissue engineering full-thickness skin model, and the construction method of the model includes: S101: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.2. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 6 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 2 hours to obtain collagen gel.
[0029] S102: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 1 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 3 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 50μg / ml vitamin C solution. The small chamber containing the collagen gel is placed in a carbon dioxide incubator for 7 days, and the liquid is changed every two days to obtain the dermis.
[0030] S103: After the dermis layer culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the chamber. 200 μl of the mixture of matrix gel and fibronectin is added to each well of the chamber and cultured in a carbon dioxide incubator for 1 hour to allow the matrix gel and fibronectin to coat the surface of the dermis layer to obtain a coated dermis layer. Among them, the volume ratio of matrix gel and fibronectin is 8:1. The matrix gel is diluted with DMEM, and the dilution volume ratio of matrix gel to DMEM is 1:2. The final concentration of fibronectin is 5 μg / ml.
[0031] S104: After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and left to stand at room temperature for 1 hour to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 1×10 5 Cells / cm 2 . After the standing period, culture solution II was added inside and outside the chamber, and the liquid level inside and outside the chamber was balanced. Then the cells were placed in a carbon dioxide incubator for 7 days. In the present application, culture solution II includes 70% DMEM, 30% F12, 2% FBS, 0.5 μg / ml hydrocortisone, 5 μg / ml insulin, 50 μg / ml adenine, 2 nM selenium, 0.2 nM progesterone, 20 ng / ml transferrin and 10 ng / ml epidermal growth factor.
[0032] S105: After the epidermal cell culture was completed, the culture medium II was replaced with culture medium III and then the air-liquid interface culture was performed for 14 days, and the culture medium was replaced every day to obtain a full-thickness skin model. Among them, the culture medium III included 50% DMEM, 50% F12, 10% FBS, 0.5μg / ml hydrocortisone, 5μg / ml insulin, 50μg / ml adenine, 0.2nM selenium, 0.1nM progesterone, 20ng / ml transferrin, 10ng / ml epidermal growth factor, and 50μg / ml vitamin C.
[0033] Example 2 The present application embodiment provides a tissue engineering full-thickness skin model, and the construction method of the model includes: S201: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.2. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 6 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 2 hours to obtain collagen gel.
[0034] S202: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 1 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 3 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 50μg / ml vitamin C solution. The small chamber containing the collagen gel is placed in a carbon dioxide incubator for 7 days, and the liquid is changed every two days to obtain the dermis.
[0035] S203: After the dermis layer culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the chamber. 200 μl of a mixture of matrix gel and fibronectin is added to each well of the chamber and cultured in a carbon dioxide incubator for 1 hour to allow the matrix gel and fibronectin to coat the surface of the dermis layer to obtain a coated dermis layer. The volume ratio of matrix gel and fibronectin is 6:1. The matrix gel is diluted with DMEM, and the dilution volume ratio of matrix gel to DMEM is 1:5. The final concentration of fibronectin is 20 μg / ml.
[0036] S204: After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and left to stand at room temperature for 2 h to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 1×10 5 Cells / cm 2 . After standing, add culture solution II to the inside and outside of the chamber, and ensure that the liquid level inside and outside the chamber is balanced. Then place it in a carbon dioxide incubator and culture it for 2 days. In this application, culture solution II includes 70% DMEM, 30% F12, 2% FBS, hydrocortisone 0.5μg / ml, insulin 5μg / ml, adenine 50μg / ml, selenium 2nM, progesterone 0.2nM, transferrin 20ng / ml and epidermal growth factor 10ng / ml.
[0037] S205: After the epidermal cell culture is completed, the culture medium II is replaced with the culture medium III and then the air-liquid interface culture is carried out for 7 days, and the culture medium is replaced every day to obtain a full-thickness skin model. Among them, the culture medium III includes 50% DMEM, 50% F12, 10% FBS, hydrocortisone 0.5μg / ml, insulin 5μg / ml, adenine 50μg / ml, selenium 0.2nM, progesterone 0.1nM, transferrin 20ng / ml, epidermal growth factor 10ng / ml, vitamin C 50μg / ml.
[0038] Example 3 The present application embodiment provides a tissue engineering full-thickness skin model, and the construction method of the model includes: S301: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.2. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 6 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 2 hours to obtain collagen gel.
[0039] S302: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 1 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 3 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 50μg / ml vitamin C solution. The small chamber containing the collagen gel is placed in a carbon dioxide incubator for 7 days, and the liquid is changed every two days to obtain the dermis.
[0040] S303: After the dermis layer culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the chamber. 200 μl of the mixture of matrix gel and fibronectin is added to each well of the chamber and cultured in a carbon dioxide incubator for 1 hour to allow the matrix gel and fibronectin to coat the surface of the dermis layer to obtain a coated dermis layer. The volume ratio of matrix gel and fibronectin is 8:1. The matrix gel is diluted with DMEM, and the dilution volume ratio of matrix gel to DMEM is 1:10. The final concentration of fibronectin is 100 μg / ml.
[0041] S304: After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and left to stand at room temperature for 1 hour to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 1×10 5 Cells / cm 2 . After standing, add culture solution II to the inside and outside of the chamber, and ensure that the liquid level inside and outside the chamber is balanced. Then place it in a carbon dioxide incubator for 5 days. In this application, culture solution II includes 70% DMEM, 30% F12, 2% FBS, hydrocortisone 0.5μg / ml, insulin 5μg / ml, adenine 50μg / ml, selenium 2nM, progesterone 0.2nM, transferrin 20ng / ml and epidermal growth factor 10ng / ml.
[0042] S305: After the epidermal cell culture is completed, the culture medium II is replaced with the culture medium III and then the air-liquid interface culture is carried out for 10 days, and the culture medium is replaced every day to obtain a full-thickness skin model. Among them, the culture medium III includes 50% DMEM, 50% F12, 10% FBS, 0.5μg / ml hydrocortisone, 5μg / ml insulin, 50μg / ml adenine, 0.2nM selenium, 0.1nM progesterone, 20ng / ml transferrin, 10ng / ml epidermal growth factor, and 50μg / ml vitamin C.
[0043] Example 4 The present application embodiment provides a tissue engineering full-thickness skin model, and the construction method of the model includes: S401: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.4. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 5 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 0.5 h to obtain collagen gel.
[0044] S402: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 0.3 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 1 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 60μg / ml vitamin C solution. The small chamber containing the collagen gel is placed in a carbon dioxide incubator for 3 days, and the liquid is changed every two days to obtain the dermis.
[0045] S403: After the dermis layer culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the chamber. 200 μl of a mixture of matrix gel and fibronectin is added to each well of the chamber and cultured in a carbon dioxide incubator for 0.5 h to allow the matrix gel and fibronectin to coat the surface of the dermis layer to obtain a coated dermis layer. The volume ratio of matrix gel and fibronectin is 10:1. The matrix gel is diluted with DMEM, and the dilution volume ratio of matrix gel to DMEM is 1:1. The final concentration of fibronectin is 10 μg / ml.
[0046] S404: After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and allowed to stand at room temperature for 0.5 h to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 2×10 5 Cells / cm 2 . After standing, add culture solution II to the inside and outside of the chamber, and ensure that the liquid level inside and outside the chamber is balanced. Then place it in a carbon dioxide incubator and culture it for 5 days. In this application, culture solution II includes 70% DMEM, 30% F12, 0.1% FBS, hydrocortisone 0.2μg / ml, insulin 1μg / ml, adenine 10μg / ml, selenium 0.05nM, progesterone 0.1nM, transferrin 10ng / ml and epidermal growth factor 0.2ng / ml.
[0047] S405: After the epidermal cell culture is completed, the culture medium II is replaced with the culture medium III and then the air-liquid interface culture is carried out for 10 days, and the culture medium is replaced every day to obtain a full-thickness skin model. Among them, the culture medium III includes 50% DMEM, 50% F12, 1% FBS, hydrocortisone 0.2μg / ml, insulin 1μg / ml, adenine 10μg / ml, selenium 0.05nM, progesterone 0.1nM, transferrin 10ng / ml, epidermal growth factor 0.2ng / ml, vitamin C 60μg / ml.
[0048] Example 5 The present application embodiment provides a tissue engineering full-thickness skin model, and the construction method of the model includes: S501: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.4. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 3×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 6 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 1.5 hours to obtain collagen gel.
[0049] S502: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 0.5 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 2 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 100 μg / ml vitamin C solution. The small chamber containing the collagen gel is placed in a carbon dioxide incubator for 6 days, and the liquid is changed every two days to obtain the dermis.
[0050] S503: After the dermis layer culture is completed, the culture medium is discarded and 1 ml of culture medium I is added to the outside of the chamber. 200 μl of the mixture of matrix gel and fibronectin is added to each well of the chamber and cultured in a carbon dioxide incubator for 1 hour to allow the matrix gel and fibronectin to coat the surface of the dermis layer to obtain a coated dermis layer. The volume ratio of matrix gel and fibronectin is 5:1. The matrix gel is diluted with DMEM, and the dilution volume ratio of matrix gel to DMEM is 1:8. The final concentration of fibronectin is 80 μg / ml.
[0051] S504: After the dermis layer is coated, the uncoated mixture is discarded, and 150 μl of epidermal cell suspension is added to each well and allowed to stand at room temperature for 1.5 h to ensure that the epidermal cells are evenly attached to the wall. The amount of epidermal cells used is 3×10 6 Cells / cm 2 . After standing, add culture solution II to the inside and outside of the chamber, and ensure that the liquid level inside and outside the chamber is balanced. Then place it in a carbon dioxide incubator for 5 days. In this application, culture solution II includes 70% DMEM, 30% F12, 10% FBS, hydrocortisone 0.8μg / ml, insulin 50μg / ml, adenine 50μg / ml, selenium 2nM, progesterone 3nM, transferrin 15ng / ml and epidermal growth factor 5ng / ml.
[0052] S505: After the epidermal cell culture is completed, the culture medium II is replaced with the culture medium III and then the air-liquid interface culture is carried out for 12 days, and the culture medium is replaced every day to obtain a full-thickness skin model. Among them, the culture medium III includes 50% DMEM, 50% F12, 10% FBS, hydrocortisone 0.8μg / ml, insulin 50μg / ml, adenine 50μg / ml, selenium 2nM, progesterone 3nM, transferrin 20ng / ml, epidermal growth factor 5ng / ml, vitamin C 70μg / ml.
[0053] Control group The control group provides a tissue engineering full-thickness skin model, and the construction method of the model includes: D101: After mixing bovine type I collagen, newborn calf serum, 10×DEME and chondroitin sulfate in a volume ratio of 7:1:1:1, add 1 mol / L NaOH solution to adjust the pH value of the mixture to 7.2. Add 500 μl of dermal fibroblast suspension to the mixture after adjusting the pH value and mix well. The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in DMEM medium containing 10% FBS. The amount of dermal fibroblasts used is 1×10 per ml of the mixture formed by mixing bovine type I collagen, etc. 6 The above mixture was added into the transwell insert chamber of a six-well plate and cultured in a carbon dioxide incubator for 2 hours to obtain collagen gel.
[0054] D102: Compress the collagen gel using a compression device until the thickness of the collagen gel reaches 1 mm. Add culture solution I to the compressed collagen gel, and ensure that the liquid volume in the small chamber reaches 3 ml, and the liquid volume outside the small chamber is equal to the liquid volume in the small chamber. Among them, culture solution I is DMEM culture medium containing 10% FBS and 50μg / ml vitamin C solution. The small chamber containing collagen gel is placed in a carbon dioxide incubator for 7 days, and the liquid is changed every two days to obtain the dermis.
[0055] D103: After the dermis culture was completed, the culture medium was discarded and 150 μl of epidermal cell suspension was added to each well and allowed to stand at room temperature for 1 h to ensure that the epidermal cells were evenly attached to the wall. The amount of epidermal cells used was 1×10 5 Cells / cm 2. After the standing period, culture solution II was added inside and outside the chamber, and the liquid level inside and outside the chamber was balanced. Then the cells were placed in a carbon dioxide incubator for 7 days. In the present application, culture solution II includes 70% DMEM, 30% F12, 2% FBS, 0.5 μg / ml hydrocortisone, 5 μg / ml insulin, 50 μg / ml adenine, 2 nM selenium, 0.2 nM progesterone, 20 ng / ml transferrin and 10 ng / ml epidermal growth factor.
[0056] D104: After the epidermal cell culture was completed, the culture medium II was replaced with culture medium III and then the air-liquid interface culture was carried out for 14 days, and the culture medium was replaced every day to obtain a full-thickness skin model. Among them, the culture medium III included 50% DMEM, 50% F12, 10% FBS, 0.5μg / ml hydrocortisone, 5μg / ml insulin, 50μg / ml adenine, 0.2nM selenium, 0.1nM progesterone, 20ng / ml transferrin, 10ng / ml epidermal growth factor, and 50μg / ml vitamin C.
[0057] In the examples of the present application, the full-thickness skin models prepared in Example 1 and the control group were subjected to conventional paraffin sectioning, and the section thickness was about 4 μm. The sliced Example 1 and the control group were subjected to HE staining, type IV collagen staining, type VII collagen staining and transcutaneous electrical resistance test, respectively. Among them, HE staining is used to observe the histological structure of the full-thickness skin model. Type IV collagen staining and type VII collagen staining are immunohistochemical staining, which are used to observe the basement membrane components of the full-thickness skin model. The transcutaneous electrical resistance test is used to detect the barrier function of the model. The following are detailed descriptions.
[0058] 1. HE staining The whole-thickness skin models of Example 1 and the control group were sliced and HE-stained respectively. After the staining, the slices were fixed and sealed, and the HE staining was observed under a microscope to obtain the attached Figure 1 , 2 . Among them, the specific steps of HE staining are: xylene staining 3 times, 4 minutes each time; 100% ethanol staining 2 times, 4 minutes each time; 95% ethanol staining 2 times, 4 minutes each time; 95% ethanol staining 4 minutes; 70% ethanol staining 4 minutes. After rinsing with distilled water, hematoxylin staining for 4 minutes, washing with water for 5 minutes, eosin staining for 30 seconds, 70% ethanol staining 2 times, 15 seconds each time; 75% ethanol staining 2 times, 15 seconds each time; 95% ethanol staining 15 seconds, 100% ethanol staining 2 times, 30 seconds each time; xylene staining 2 times, 5 minutes each time.
[0059] By the attached Figure 1 , 2It can be seen that after HE staining, the full-thickness skin model in Example 1 formed a basement membrane between the epidermis and the dermis, which were tightly connected and difficult to separate when sliced. After HE staining, the full-thickness skin model in Control Group 1 did not form a basement membrane between the epidermis and the dermis, which were not tightly connected and were easily separated when sliced.
[0060] 2. Type IV / VII collagen staining The whole-thickness skin models of Example 1 and the control group were sliced and stained for type IV / VII collagen, and the HE staining was observed under a microscope after the staining to obtain the attached Figure 3-6 Among them, the specific steps of type IV / VII collagen staining are: conventional immunohistochemical staining, the primary antibody is mouse anti-human type IV / VII collagen monoclonal antibody (1:150), the secondary antibody is horseradish peroxidase-labeled goat anti-mouse antibody, ABC method, diaminobenzidine color development, and hematoxylin counterstaining.
[0061] By the attached Figure 3 , 4 It can be seen that after the full-thickness skin model in Example 1 was stained with type IV / VII collagen, the type IV collagen and type VII collagen in the epidermis and dermis were uniformly colored.
[0062] By the attached Figure 5 , 6 It can be seen that after type IV / VII collagen staining, the epidermis and dermis were completely separated in the full-thickness skin model in control group 1, and there was no type IV and type VII collagen staining.
[0063] 3. Transcutaneous resistance test The transcutaneous resistance meter was used to test the transmembrane resistance of the full-thickness skin models after slicing in Examples 1, 2, 3 and the control group, respectively. The test conditions were the same, and the test results are shown in Table 1.
[0064] Table 1: Transcutaneous electrical resistance test results As can be seen from Table 1, the transcutaneous resistance values of the full-thickness skin models in Examples 1, 2, and 3 are higher than the transcutaneous resistance value of the full-thickness skin model in the control group, which indicates that the barrier function of the full-thickness skin model prepared in the examples of the present application is better than that of the full-thickness skin model prepared in the control group.
[0065] In summary, after corresponding tests, in the full-thickness skin model provided in the embodiment of the present application, the epidermis and the dermis are tightly connected through the basement membrane, and the color development of type IV collagen staining and type VII collagen staining of the basement membrane part is very uniform; at the same time, the transepidermal resistance value of the full-thickness skin model is relatively high, and it has excellent barrier function.
[0066] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A method for constructing a tissue engineering full-thickness skin model, characterized in that: include: Mix bovine type I collagen, newborn bovine serum, 10×DEME and chondroitin sulfate, adjust the pH value to 7.2-7.4, add dermal fibroblast suspension, mix well, and culture in a carbon dioxide incubator for 0.5-2 hours to obtain collagen gel; After compressing the collagen gel to a thickness of 0.3-1 mm, culture medium I is added and cultured for 3-7 days to obtain a dermis layer; The dermis layer is coated with matrix gel and fibronectin, and cultured in a carbon dioxide incubator for 0.5-1 hour to obtain a coated dermis layer; The epidermal cell suspension is added to the coated dermis layer, left to stand at room temperature, culture medium II is added after adherence culture, and culture is carried out in a carbon dioxide incubator for 2-7 days; After the culture is completed, the culture medium II is replaced with culture medium III and then cultured at the air-liquid interface for 7-14 days to obtain a full-thickness skin model.
2. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The matrix gel is diluted with DMEM, and the dilution volume ratio of the matrix gel to the DMEM is 1: (1-10).
3. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The final concentration of the fibronectin is 5-100 μg / ml.
4. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The culture medium I is a DMEM culture medium containing 10% FBS and 50-100 μg / ml vitamin C solution.
5. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The culture medium II includes 70% DMEM, 30% F12, 0.1-10% FBS, 0.2-0.8 μg / ml of hydrocortisone, 1-50 μg / ml of insulin, 10-50 μg / ml of adenine, 0.05-2 nM of selenium, 0.1-3 nM of progesterone, 10-20 ng / ml of transferrin and 0.2-10 ng / ml of epidermal growth factor.
6. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The culture medium III includes 50% DMEM, 50% F12, 1-10% FBS, 0.2-0.8 μg / ml of hydrocortisone, 1-50 μg / ml of insulin, 10-50 μg / ml of adenine, 0.05-2 nM of selenium, 0.1-3 nM of progesterone, 10-20 ng / ml of transferrin, 0.2-10 ng / ml of epidermal growth factor, and 50-100 μg / ml of vitamin C.
7. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The dermal fibroblast suspension is prepared by resuspending dermal fibroblasts in a DMEM culture medium containing 10% FBS.
8. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The amount of dermal fibroblasts used is 1×10 5 -3×10 6 cells / ml.
9. The method for constructing a tissue engineering full-thickness skin model according to claim 1, characterized in that: The amount of epidermal cells used is 1×10 5 -3×10 6 Cells / cm 2 .
10. A tissue engineering full-thickness skin model constructed by the method for constructing a tissue engineering full-thickness skin model according to any one of claims 1 to 9.
Citation Information
Cited By
Method for evaluating anti-aging effect of filler
CN119410745A
Preparation method of nano embedding composition for cosmetics
CN122031342A
